Xencor, Inc.
BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS
Last updated:
Abstract:
The present invention is directed to novel bispecific heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc-fusion protein and a PD-1 antibody fragment-Fc fusion protein.
Status:
Application
Type:
Utility
Filling date:
17 Dec 2019
Issue date:
23 Apr 2020